Skip to main content
. 2021 Oct 22;59(1):294–325. doi: 10.1007/s12035-021-02585-6

Table 4.

Clinical trials of remote ischemic conditioning (RIC) targeting other cerebral diseases

Name of study Type of patients/pathology size and phase of study Primary outcomes Secondary outcomes RIC protocol* Main results/observations Status Ref
no name Symptomatic intracranial arterial stenosis proof-of-concept study, 68 patients with symptomatic intracranial arterial stenosis stroke recurrence time to which modified Rankin scale recovers to 0–1 5 cycles applied bilaterally and daily for 300 days RIC improvement of brain perfusion and reduction from 26.7% to 7.9% of stroke recurrence at day 300 completed [121]
no name Symptomatic intracranial arterial stenosis 58 octo and nonagenarian patients with symptomatic intracranial arterial stenosis stroke recurrence improvement of the NIHSS score (≥ 8 points or ≤ 1 point from the baseline) or modified Rankin scale of 0–2 5 cycles applied bilaterally and daily for 180 days no clear effect: 2 infarctions and 7 transient ischemic attacks in RIC group while 8 infarctions and 11 transient ischemic attacks in sham group completed [122]
no name Middle cerebral artery stenosis pilot study, 10 patients with unilateral MCA stenosis and 24 healthy volunteers safety and feasibility heart rate, oxygenation index or mean flow velocity 5 cycles (single application) no effect on heart rate, oxygenation index or mean flow velocity in MCA stenosis patients, but reduction on blood pressure in healthy volunteers completed [123]
no name Cervical spondylotic myelopathy patients prior to undergoing elective decompression surgery pilot study, 40 patients safety and feasibility for a larger clinical trial Median nerve somatosensory- evoked potentials (SEPs) S100ß and neuron-specific enolase plasma levels 3 cycles (single application before surgery—preconditioning) decrease of S100ß plasma concentration completed [124]
no name Aneurysmal subarachnoid hemorrhage (SAH) pilot study 4 patients Cerebral hemodynamic and metabolic features not applicable 4 cycles applied in non-consecutive days 2 to 12 days following SAH (leg) Reduction of lactate/pyruvate ration and glycerol levels in the brain; increase on intracranial pressure and decrease the mean velocities of middle cerebral artery completed [125]
no name Aneurysmal subarachnoid hemorrhage (SAH) phase I, 20 patients safety and feasibility for a larger clinical trial (development of deep venous thrombosis, bruising, or injury to the conditioned limb) development of new neurological deficits or cerebral infarct and neurological features at follow-up 4 cycles applied every other day for 12 days (leg) RIC procedure is safe and feasible completed [126]
no name Aneurysmal subarachnoid hemorrhage (SAH) phase Ib, 33 patients development of venous thrombosis or injury in the limb, safety Transcranial Doppler spasm, delayed cerebral ischemia and 3 month modified Rankin scale 3 cycles** applied every 24 or 48 h during 14 days (leg) RIC procedure is safe and feasible, with no difference in the analyzed parameters completed [127]
RICH-1 Intracranial hemorrhage Randomized pilot study safety Hematoma and perihematomal edema volume, hematoma expansion 4 cycles daily for one week cranial tomography will be performed at days 1, 3, 7 and 14 after stroke onset ongoing [128]
no name Small vessel disease—Mild cognitive impairment pilot study, 30 patients change in brain lesions changes of cognitive function, plasma biomarkers, and cerebral hemodynamic parameters at 1-year follow-up 5 cycles twice a day for 1 year RIC decreased white matter hyperintensities, improved visuospatial and executive abilities and reduced plasma levels of tryglycerides, total cholesterol, LDL and homocysteine completed [129]
no name Subcortical ischemic vascular dementia pilot study, 37 patients change in neuropsychological assessments Changes in high-sensitive C reactive protein concentration, white matter lesion volume, diffusion tension imaging metrics of white matter 5 cycles daily for 6 months RIC improved cognitive function assessed by Hopkins Verbal Learning Test-Revised, Controlled Oral Word Association Test, Trail Making Test A and B and Judgment of Line Orientation completed [130]